Skip to main content
. 2008 Oct 22;58(6):877–886. doi: 10.1007/s00262-008-0603-5

Table 1.

Clinical characteristics of study subjects

Variable Results
Sex (male/female) 28/10
Age [year, median (range)] 57 (33–81)
Tumor size (cm, mean ± SD) 6.6 ± 3.7
α-fetoprotein level [ng/ml, median (range)] 291 (0–1,210)
HBsAg positivity (%) 66
HCV antibody positivity (%) 5.3
TNM stage (I/II/III/IV) 3/12/12/11
Differentiation (high/medium/low) 4/18/2a

HBsAg hepatitis B surface antigen, HCV hepatitis C virus

aData available for 24 patients only